Brovavir: its antiherpesviral activity and mode of action.
Machida
H
H
Biology Laboratory, Yamasa Shoyu Company, Limited, Chosi-shi, Japan.
D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004279:DNA, Viral / Q000096:biosynthesis / Q000187:drug effects; D006561:Herpes Simplex / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy*; D014645:Herpesvirus 3, Human / Q000187:drug effects*; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D010766:Phosphorylation; D018139:Simplexvirus / Q000187:drug effects*; D013937:Thymidine Kinase / Q000378:metabolism
D000998:Antiviral Agents; D004279:DNA, Viral; D001086:Arabinofuranosyluracil; C031368:sorivudine; D013937:Thymidine Kinase